Response: Although we acknowledge the applicant's concerns regarding the descriptor for C1739, we do not agree that the device category code should be withdrawn and replaced with a new code effective January 1, 2026, for the following reasons: First, per the applicant's request prior to CY 2026 rulemaking, CMS revised the descriptor for C1739 to read, effective October 1, 2025: Tissue marker, uniquely detectable and identifiable with probe/sensor, any method (implantable), with delivery system
If your hiccups are accompanied by severe abdominal pain, persistent vomiting, or the inability to keep fluids down, you should contact a provider immediately to ensure your dosage is appropriate and that you are not experiencing more serious complications like pancreatitis or gallbladder issues
In the evolving GLP-1 landscape, the opportunity is not about replacing pharmaceuticals its about complementing the user journey with meaningful nutritional support
These tests rely on antibody recognition of specific drug metabolites or parent compounds
This is also when some people notice that appetite suppression lasts most of the week instead of fluctuating
